Sign in to view content

New Biosimilar Bevacizumab and Ranibizumab for Retinal Diseases

Alay S. Banker, MD

Video
Published 2018

Related

Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2019
What Is the Clinical Significance of Improving Diabetic Retinopathy for Vision Outcomes? A Meta-Analysis of 5 Ranibizumab Trials
Sophie Jane Bakri, MD
Annual Meeting Talks
2021
Outcomes of Antivascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice
Andrew A. Moshfeghi, MD, MBA, FASRS
Annual Meeting Talks
2018

Category: Retinal Vascular Disease

See more